Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy

L Santarpia, SM Lippman… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: The MAPK pathway comprises several key signaling components and
phosphorylation events that play a role in tumorigenesis. These activated kinases transmit …

Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy

BB Friday, AA Adjei - Clinical cancer research, 2008 - AACR
The identification of intracellular signaling cascades important for the growth and survival of
cancer cells has led to the development of targeted cancer therapeutics aimed at blocking …

Targeting the mitogen-activated protein kinase cascade to treat cancer

JS Sebolt-Leopold, R Herrera - Nature reviews cancer, 2004 - nature.com
The RAS–mitogen activated protein kinase (MAPK) signalling pathway has long been
viewed as an attractive pathway for anticancer therapies, based on its central role in …

Recent developments in anti-cancer agents targeting the Ras/Raf/MEK/ERK pathway

KK Wong - Recent patents on anti-cancer drug discovery, 2009 - ingentaconnect.com
The Ras/Raf/MEK/ERK mitogen-activated protein kinase (MAPK) pathway mediates cellular
responses to different growth signals and is frequently deregulated in cancer. There are …

[HTML][HTML] Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy

F Liu, X Yang, M Geng, M Huang - Acta pharmaceutica sinica B, 2018 - Elsevier
The mitogen-activated protein kinases (MAPK) pathway, often known as the RAS-RAF-MEK-
ERK signal cascade, functions to transmit upstream signals to its downstream effectors to …

Unraveling the complexities of the Raf/MAP kinase pathway for pharmacological intervention

R Herrera, JS Sebolt-Leopold - Trends in Molecular Medicine, 2002 - cell.com
The Ras–MAP kinase pathway has attracted much attention from academic and
pharmaceutical laboratories because of its central role in regulating tumor cell growth and …

The Ras-Raf-MEK-ERK pathway in the treatment of cancer

RA Hilger, ME Scheulen, D Strumberg - Oncology Research and …, 2002 - karger.com
The mitogen activated protein kinases (MAPKs) are conserved proteins that regulate cell
growth, division and death. Although activated in the cytosol, the MAPKs translocate to the …

[HTML][HTML] Progress on Ras/MAPK signaling research and targeting in blood and solid cancers

M Dillon, A Lopez, E Lin, D Sales, R Perets, P Jain - Cancers, 2021 - mdpi.com
Simple Summary The Ras-Raf-MEK-ERK signaling pathway is responsible for regulating
cell proliferation, differentiation, and survival. Overexpression and overactivation of …

Development of anticancer drugs targeting the MAP kinase pathway

JS Sebolt-Leopold - Oncogene, 2000 - nature.com
Since the discovery of the role of ras oncogenes in tumorigenesis, we have witnessed an
explosion of research in the signal transduction area. In the quest to understand how Ras …

[HTML][HTML] Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials

Y Song, Z Bi, Y Liu, F Qin, Y Wei, X Wei - Genes & diseases, 2023 - Elsevier
Molecular target inhibitors have been regularly approved by Food and Drug Administration
(FDA) for tumor treatment, and most of them intervene in tumor cell proliferation and …